Amron Arthur H reported grant involving 3,514 shares of NEPHROS INC at $0.00 for $0 on Nov 9, 2026

Grant
Form 4 code A. Grant, award, or other acquisition under Rule 16b-3(d).
Director
DIR
Filed Nov 12, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
3,514Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
162,137Direct
Trade date
Nov 9, 2026Grant
Filed
Nov 12, 2026, 4:32 PM ET3-day reporting delay
Accession
0000914190-26-000178Code A · Transaction 399109
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

No other transaction rows in this filing.

1 transaction row in this filing. Joint filers share the same rows.

NEPH price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
NEPH · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.

Return windows are pending. The first 7-day window is eligible on Nov 19, 2026. Values appear when the daily price refresh supplies a valid close for that window. Weekends, market holidays and missing prices can delay updates.

Pre-filing1mo ago +0.6%1w ago 0%1d ago 0%
Returns since7d30d90d180d1y

Footnotes in full

F1: Shares issued to the Reporting Person in lieu of cash fees for board service. F2: Held by Amron Holdings LLC, over which the Reporting Person has voting and dispositive power as its controlling person. F3: Fully vested. F4: This option vests as to 2,350 shares on each of 1/1/25, 1/1/26 and 1/1/27.